Clinical trial

Radio-Immuno-Modulation in Lung Cancer

NCT02579005

StatusSUSPENDED

Study typeINTERVENTIONAL

Start date2018-04-20

PhasePHASE1

Study timeline

Study start (actual)2018-04-20Date precision: day

Registry last updated2024-02-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

Patients with a living donorBIOLOGICAL

Patients with a UCB donorBIOLOGICAL

Sponsors & collaborators

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreallead sponsor

Maisonneuve-Rosemont Hospitalcollaborator

Mapped research locations

MontrealQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02579005 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.